Two phase II trials of temozolomide with interferon-α2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme

被引：0
|
作者：
M D Groves
V K Puduvalli
M R Gilbert
V A Levin
C A Conrad
V H Liu
K Hunter
C Meyers
K R Hess
W K Alfred Yung
机构：
[1] The University of Texas MD Anderson Cancer Center,Department of Neuro
[2] The University of Texas MD Anderson Cancer Center,Oncology
来源：
British Journal of Cancer | 2009年 / 101卷
关键词：
glioblastoma; multiforme; temozolomide; interferon; phase II;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：615 / 620
页数：5
相关论文
共 50 条
  • [1] Two phase II trials of temozolomide with interferon-α2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme
    Groves, M. D.
    Puduvalli, V. K.
    Gilbert, M. R.
    Levin, V. A.
    Conrad, C. A.
    Liu, V. H.
    Hunter, K.
    Meyers, C.
    Hess, K. R.
    Yung, W. K. Alfred
    BRITISH JOURNAL OF CANCER, 2009, 101 (04) : 615 - 620
  • [2] Phase II study of temozolomide plus pegylated interferon-α-2b for metastatic melanoma
    Hwu, Wen-Jen
    PanageaS, Katherine S.
    Menell, Jennifer H.
    Lamb, Lynne A.
    Aird, Suzan
    Krown, Susan E.
    Williams, Linda J.
    Chapman, Paul B.
    Livingston, Philip O.
    Wolchok, Jedd D.
    Houghton, Alan N.
    CANCER, 2006, 106 (11) : 2445 - 2451
  • [3] A phase II study of temozolomide plus pegylated interferon alfa-2b for recurrent anaplastic glioma and glioblastoma multiforme
    Groves, MD
    Puduvalli, V
    Gilbert, MR
    Conrad, CA
    Hsu, S
    Colman, H
    Hess, K
    Levin, VA
    Yung, WKA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 118S - 118S
  • [4] Pegylated interferon-α-2b for children with recurrent craniopharyngioma Clinical article
    Yeung, Jacky T.
    Pollack, Ian F.
    Panigrahy, Ashok
    Jakacki, Regina I.
    JOURNAL OF NEUROSURGERY-PEDIATRICS, 2012, 10 (06) : 498 - 503
  • [5] Differential Antiviral Effects of Pegylated Interferon-α2a and Pegylated Interferon-α2b in Chronic Hepatitis C
    Durante-Mangoni, Emanuele
    Parrella, Antonio
    Iossa, Domenico
    Andini, Roberto
    Molaro, Rosa
    Battimelli, Carminia
    Sodano, Giuseppe
    Utili, Riccardo
    CLINICAL DRUG INVESTIGATION, 2014, 34 (12) : 871 - 878
  • [6] Differential Antiviral Effects of Pegylated Interferon-α2a and Pegylated Interferon-α2b in Chronic Hepatitis C
    Emanuele Durante-Mangoni
    Antonio Parrella
    Domenico Iossa
    Roberto Andini
    Rosa Molaro
    Carminia Battimelli
    Giuseppe Sodano
    Riccardo Utili
    Clinical Drug Investigation, 2014, 34 : 871 - 878
  • [7] Phase I trial of pegylated interferon-α-2b in young patients with plexiform neurofibromas
    Jakacki, R. I.
    Dombi, E.
    Potter, D. M.
    Goldman, S.
    Allen, J. C.
    Pollack, I. F.
    Widemann, B. C.
    NEUROLOGY, 2011, 76 (03) : 265 - 272
  • [8] Phase II study of temozolomide (TMZ) and pegylated interferon α-2b (PGI) in the treatment of advanced melanoma.
    Krown, SE
    Hwu, WJ
    Menell, JH
    Panageas, KS
    Lamb, LA
    Aird, S
    Williams, LJ
    Chapman, PB
    Livingston, PO
    Wolchok, JD
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 718S - 718S
  • [9] Treatment of chronic hepatitis delta with pegylated interferon-α2b
    Erhardt, Andreas
    Gerlich, Wolfram
    Starke, Christine
    Wend, Ulrike
    Donner, Andreas
    Sagir, Abdurrahman
    Heintges, Tobias
    Haeussinger, Dieter
    LIVER INTERNATIONAL, 2006, 26 (07) : 805 - 810
  • [10] Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial
    Egberts, F.
    Gutzmer, R.
    Ugurel, S.
    Becker, J. C.
    Trefzer, U.
    Degen, A.
    Schenck, F.
    Frey, L.
    Wilhelm, T.
    Hassel, J. C.
    Schadendorf, D.
    Livingstone, E.
    Mauch, C.
    Garbe, C.
    Berking, C.
    Rass, K.
    Mohr, P.
    Kaehler, K. C.
    Weichenthal, M.
    Hauschild, A.
    ANNALS OF ONCOLOGY, 2011, 22 (07) : 1667 - 1674
12345